Fig. 1From: Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolatesAntimicrobial activity of AMP2041 on a P. aeruginosa clinical isolates and b P. aeruginosa isolates from a patient with cystic fibrosis. c Time-kill assayBack to article page